Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Tofacitinib significantly improved skin and hair conditions without side effects.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Tofacitinib treatment is used for teenagers with alopecia areata.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

The serum with microneedling device improves hair loss treatment effectively and safely.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

The polyherbal emulgel is a promising treatment for rheumatoid arthritis with effective and sustained results.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

A 44-year-old woman with Down's syndrome was diagnosed with both rheumatoid and gouty arthritis and treated with multiple medications.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Tofacitinib helped a woman regrow hair with no major side effects.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

A girl with a rare skin condition improved after one month of treatment with acitretin.